These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone. Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T. Diabet Med; 1996 Apr; 13(4):365-70. PubMed ID: 9162613 [Abstract] [Full Text] [Related]
34. The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe. Veneman TF, Tack CJ, van Haeften TW. Neth J Med; 1998 May; 52(5):179-86. PubMed ID: 9652156 [Abstract] [Full Text] [Related]
36. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential. Østoft SH. Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089 [Abstract] [Full Text] [Related]
40. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man. Raptis SA, Hatziagelaki E, Dimitriadis G, Draeger KE, Pfeiffer C, Raptis AE. Exp Clin Endocrinol Diabetes; 1999 Nov; 107(6):350-5. PubMed ID: 10543411 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]